Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: An exploratory study

Diabetes, Obesity and Metabolism

Volumn 10, Issue 6, 2008, Pages 484-491

  Horvath, Karl ^a   Bock, G ^a   Regittnig, W ^a   Bodenlenz, M ^a   Wutte, A ^a   Plank, J ^a   Magnes, C ^a   Sinner, F ^a   Furst recktenwald S ^b   Theobald, K ^b   Pieber, T R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Euglycaemic glucose clamp; Glulisine; Lispro

Indexed keywords

FATTY ACID; GLUCOSE; GLYCEROL; HUMAN INSULIN; INSULIN; INSULIN GLULISINE; INSULIN LISPRO; LACTIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EVIDENCE BASED MEDICINE; EXPLORATORY RESEARCH; FATTY ACID BLOOD LEVEL; FEMALE; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; GLYCEROL BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; LACTATE BLOOD LEVEL; LATIN SQUARE DESIGN; LOW DRUG DOSE; MALE; PHARMACODYNAMICS; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 43149086382     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2007.00734.x     Document Type: Article

References (25)